Showing results (131-140 of 143) with videos related to
Sort By:
Pageof 15
Clinical Immunology (Orlando, Fla.)|July 5, 2016
Highly specific and potently activating Vγ9Vδ2-T cell specific nanobodies for diagnostic and therapeutic applicationsRenée C G de Bruin, Sinéad M Lougheed, Liza van der Kruk, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 30, 2016
Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR NanobodyRenée C G de Bruin, Anita G M Stam, Anna Vangone, et al.Nature Communications|August 12, 2015
Resolving bundled microtubules using anti-tubulin nanobodiesMarina Mikhaylova, Bas M C Cloin, Kieran Finan, et al.Oncoimmunology|January 4, 2018
ATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapySeandean Lykke Harwood, Ana Alvarez-Cienfuegos, Natalia Nuñez-Prado, et al.The FEBS Journal|March 18, 2020
Site-specific functionality and tryptophan mimicry of lipidation in tetraspanin CD9Viviana Neviani, Sjoerd van Deventer, Tobias P Wörner, et al.International Journal of Cancer|November 14, 2013
Intraoperative fluorescence delineation of head and neck cancer with a fluorescent anti-epidermal growth factor receptor nanobodyP B A A van Driel, J R van der Vorst, F P R Verbeek, et al.Cell|November 15, 2016
EGFR Dynamics Change during Activation in Native Membranes as Revealed by NMRMohammed Kaplan, Siddarth Narasimhan, Cecilia de Heus, et al.Theranostics|February 25, 2020
Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imagingHenriette S de Bruijn, Vida Mashayekhi, Tom J L Schreurs, et al.Theranostics|January 22, 2024
Erratum: Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging: ErratumHenriette S de Bruijn, Vida Mashayekhi, Tom J L Schreurs, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 19, 2016
EGFR targeted nanobody-photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancerPieter B A A van Driel, Martin C Boonstra, Maxime D Slooter, et al.Pageof 15